242 related articles for article (PubMed ID: 11529230)
21. Temozolomide for advanced, metastatic melanoma.
Cohen MH; Johnson JR; Middleton MR
J Clin Oncol; 2000 May; 18(10):2185. PubMed ID: 10811684
[No Abstract] [Full Text] [Related]
22. Acquired hypopigmentation (leukoderma) as a presenting feature of metastatic amelanotic melanoma with brain involvement.
Karakis I; McGeeney B; Demierre MF; Thiele JJ; Wolpowitz D; Bhawan J
Arch Neurol; 2007 Dec; 64(12):1786-7. PubMed ID: 18071045
[No Abstract] [Full Text] [Related]
23. Temozolomide in advanced malignant melanoma with small brain metastases: can we withhold cranial irradiation?
Boogerd W; de Gast GC; Dalesio O
Cancer; 2007 Jan; 109(2):306-12. PubMed ID: 17149755
[TBL] [Abstract][Full Text] [Related]
24. Leptomeningeal metastases from small cell lung cancer responsive to temozolomide therapy.
Zauderer M; Krug LM; Pietanza MC; O'Rourke D
J Thorac Oncol; 2010 Oct; 5(10):1716-7. PubMed ID: 20871272
[No Abstract] [Full Text] [Related]
25. Hemorrhagic cystitis in a patient receiving conventional doses of dacarbazine for metastatic malignant melanoma: case report and review of the literature.
Mohammadianpanah M; Shirazi M; Mosalaei A; Omidvari S; Ahmadloo N
Clin Ther; 2007 Jun; 29(6):1161-5. PubMed ID: 17692730
[TBL] [Abstract][Full Text] [Related]
26. [Therapy of malignant melanoma at the stage of distant metastasis].
Garbe C; Eigentler TK
Hautarzt; 2004 Feb; 55(2):195-213. PubMed ID: 15043023
[TBL] [Abstract][Full Text] [Related]
27. Phase II trial of arsenic trioxide and ascorbic acid with temozolomide in patients with metastatic melanoma with or without central nervous system metastases.
Bael TE; Peterson BL; Gollob JA
Melanoma Res; 2008 Apr; 18(2):147-51. PubMed ID: 18337652
[TBL] [Abstract][Full Text] [Related]
28. Treatment of metastatic melanoma in the brain with temozolomide and thalidomide.
Hwu WJ; Raizer J; Panageas KS; Lis E
Lancet Oncol; 2001 Oct; 2(10):634-5. PubMed ID: 11902555
[No Abstract] [Full Text] [Related]
29. Temozolomide: a novel oral alkylating agent.
Danson SJ; Middleton MR
Expert Rev Anticancer Ther; 2001 Jun; 1(1):13-9. PubMed ID: 12113120
[TBL] [Abstract][Full Text] [Related]
30. Dacarbazine but not temozolomide induces phototoxic dermatitis in patients with malignant melanoma.
Treudler R; Georgieva J; Geilen CC; Orfanos CE
J Am Acad Dermatol; 2004 May; 50(5):783-5. PubMed ID: 15097966
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and side effects of dacarbazine in comparison with temozolomide in the treatment of malignant melanoma: a meta-analysis consisting of 1314 patients.
Teimouri F; Nikfar S; Abdollahi M
Melanoma Res; 2013 Oct; 23(5):381-9. PubMed ID: 23880781
[TBL] [Abstract][Full Text] [Related]
32. Possible efficacy of temozolomide in a patient with gliomatosis cerebri.
Benjelloun A; Delavelle J; Lazeyras F; Dietrich PY
Neurology; 2001 Nov; 57(10):1932-3. PubMed ID: 11723300
[No Abstract] [Full Text] [Related]
33. Does addition of temozolomide to whole brain radiotherapy improve outcome in patients with brain metastases?
Erridge SC; Gregor A
Nat Clin Pract Oncol; 2005 Apr; 2(4):194-5. PubMed ID: 16264933
[No Abstract] [Full Text] [Related]
34. A phase II trial of temozolomide for patients with recurrent or progressive brain metastases.
Abrey LE; Olson JD; Raizer JJ; Mack M; Rodavitch A; Boutros DY; Malkin MG
J Neurooncol; 2001 Jul; 53(3):259-65. PubMed ID: 11718258
[TBL] [Abstract][Full Text] [Related]
35. Multiple cerebral hemorrhagic foci from metastases during temozolomide treatment in a patient with corticotroph pituitary carcinoma.
Mendola M; Passeri E; Ambrosi B; Corbetta S
J Clin Endocrinol Metab; 2014 Aug; 99(8):2623-4. PubMed ID: 24823463
[No Abstract] [Full Text] [Related]
36. Medical treatment and other combination regimens.
Bajetta E; Del Vecchio M; Bajetta R; Canova S
Tumori; 2007; 93(3):suppl 22-6. PubMed ID: 17679485
[No Abstract] [Full Text] [Related]
37. Management of malignant melanoma: best practices.
Smylie M; Claveau J; Alanen K; Taillefer R; George R; Wong R; Mason WP;
J Cutan Med Surg; 2009; 13(2):55-73. PubMed ID: 19459245
[TBL] [Abstract][Full Text] [Related]
38. Survival over 6 years in a patient with brain metastases from melanoma treated with temozolomide.
Koekkoek JA; Wiggenraad RG; Zwinkels H; Oosterkamp HM; Taphoorn MJ
BMJ Case Rep; 2012 Sep; 2012():. PubMed ID: 23008380
[TBL] [Abstract][Full Text] [Related]
39. Association of vitiligo and response in patients with metastatic malignant melanoma on temozolomide.
Tatli AM; Besen AA; Kalender ME; Uysal M; Aslan D; Goksu SS; Gunduz SG; Coskun HS
Tumori; 2015; 101(2):e67-9. PubMed ID: 25702668
[TBL] [Abstract][Full Text] [Related]
40. Recurrent PNET with MGMT methylation responds to temozolomide.
Oh J; Bilbao JM; Tsao MN; Fazl M; Guiot MC; Del Maestro RF; Perry JR
Can J Neurol Sci; 2009 Sep; 36(5):654-7. PubMed ID: 19831139
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
